迈克生物
(300463)
| 流通市值：71.56亿 | | | 总市值：89.18亿 |
| 流通股本：4.92亿 | | | 总股本：6.12亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 829,961,103.27 | 952,967,324.8 | 819,182,542.14 | 835,957,326.8 |
| 应收票据及应收账款 | 1,578,729,040.93 | 1,672,999,047.46 | 1,738,359,591.84 | 1,793,562,431.7 |
| 其中：应收票据 | 16,347,289.16 | 26,786,346.2 | 30,839,801.25 | 20,258,570.53 |
| 应收账款 | 1,562,381,751.77 | 1,646,212,701.26 | 1,707,519,790.59 | 1,773,303,861.17 |
| 应收款项融资 | 17,033,778.15 | 23,110,385.85 | 33,969,572.52 | 40,087,754.03 |
| 预付款项 | 152,366,844.25 | 190,346,149.83 | 236,400,953.65 | 193,690,189.35 |
| 其他应收款合计 | 24,467,709.59 | 29,248,307.89 | 28,984,654.5 | 27,651,809.87 |
| 存货 | 1,002,786,973.53 | 990,960,797.1 | 1,009,803,399.09 | 907,488,528.28 |
| 其他流动资产 | 176,581,040.68 | 150,823,705.44 | 114,066,380.79 | 112,635,352.15 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,902,000,019.17 | 4,150,647,134.81 | 4,121,289,063.21 | 4,222,217,919.77 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 129,129,318.05 | 138,294,039.33 | 139,340,058.54 | 139,767,887.32 |
| 其他非流动金融资产 | 25,360,263.52 | 31,689,366.67 | 31,996,437.55 | 32,957,264.85 |
| 投资性房地产 | 65,126,879.47 | 65,591,168.65 | 66,055,457.83 | 66,519,747.01 |
| 固定资产 | 2,295,945,340.09 | 2,240,539,364.98 | 2,194,615,191.38 | 2,186,644,511.57 |
| 在建工程 | 1,009,510,329.56 | 911,304,521.63 | 811,872,935.65 | 714,480,697.52 |
| 使用权资产 | 18,892,231.62 | 22,447,547.46 | 24,796,080.81 | 28,328,456.06 |
| 无形资产 | 336,120,654.9 | 296,041,337.04 | 305,413,446.66 | 283,250,717.77 |
| 开发支出 | 123,817,482.31 | 147,053,882.51 | 125,343,217.81 | 137,544,414.42 |
| 商誉 | 145,145,637.79 | 145,145,637.79 | 145,145,637.79 | 145,145,637.79 |
| 长期待摊费用 | 3,418,408.32 | 4,040,340.48 | 4,661,374.4 | 4,860,298.96 |
| 递延所得税资产 | 147,752,804.57 | 146,674,423.68 | 150,301,980.38 | 153,863,904.46 |
| 其他非流动资产 | 3,667,850.43 | 3,667,850.43 | 3,667,850.43 | 3,667,850.43 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,303,887,200.63 | 4,152,489,480.65 | 4,003,209,669.23 | 3,897,031,388.16 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 8,205,887,219.8 | 8,303,136,615.46 | 8,124,498,732.44 | 8,119,249,307.93 |
| 流动负债: | | | | |
| 短期借款 | 340,741,907.47 | 253,330,953.98 | 198,264,245.11 | 144,647,498.1 |
| 应付票据及应付账款 | 265,328,002.19 | 273,652,806.94 | 289,346,806.8 | 365,846,161.95 |
| 其中：应付票据 | 21,963,073.56 | 9,741,657.97 | 22,444,386.4 | 80,472,270 |
| 应付账款 | 243,364,928.63 | 263,911,148.97 | 266,902,420.4 | 285,373,891.95 |
| 合同负债 | 80,397,678.59 | 86,725,463.23 | 84,087,896.15 | 72,358,985.11 |
| 应付职工薪酬 | 46,417,706.6 | 49,347,903.59 | 49,108,655.23 | 116,724,296.57 |
| 应交税费 | 32,159,243.61 | 25,149,074.56 | 36,767,207.91 | 41,002,035.55 |
| 其他应付款合计 | 202,887,367.36 | 137,367,704.45 | 22,889,667.94 | 24,995,300.22 |
| 应付股利 | 145,200,000 | 94,058,297.22 | - | - |
| 一年内到期的非流动负债 | 261,102,125.28 | 406,451,682.06 | 391,919,677.7 | 345,039,677.7 |
| 其他流动负债 | 9,808,002.71 | 10,762,920.18 | 10,087,651.02 | 9,991,155.32 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,238,842,033.81 | 1,242,788,508.99 | 1,082,471,807.86 | 1,120,605,110.52 |
| 非流动负债: | | | | |
| 长期借款 | 142,641,909.85 | 144,641,909.85 | 112,000,000 | 162,500,000 |
| 租赁负债 | 8,345,472.38 | 12,105,727.08 | 9,428,919.74 | 12,977,946.3 |
| 预计负债 | 3,580,000 | 3,740,000 | 3,828,800 | 3,828,800 |
| 递延收益 | 26,261,835.88 | 25,261,835.88 | 28,801,835.88 | 28,801,835.88 |
| 递延所得税负债 | 167,866,698.96 | 176,851,077.33 | 175,484,420.49 | 179,073,594.69 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 348,695,917.07 | 362,600,550.14 | 329,543,976.11 | 387,182,176.87 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,587,537,950.88 | 1,605,389,059.13 | 1,412,015,783.97 | 1,507,787,287.39 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 612,469,590 | 612,469,590 | 612,469,590 | 612,469,590 |
| 资本公积 | 1,788,936,923.61 | 1,782,965,505.18 | 1,780,989,744.69 | 1,780,989,744.69 |
| 减:库存股 | 206,037,569.27 | 193,061,728.79 | 193,040,926.79 | 170,181,677.97 |
| 其他综合收益 | 5,850,480.57 | 13,640,493.66 | 14,529,615.09 | 14,893,264.45 |
| 盈余公积 | 306,234,795 | 306,234,795 | 306,234,795 | 306,234,795 |
| 未分配利润 | 4,027,733,640.18 | 3,948,086,971.04 | 3,960,861,803.07 | 3,840,419,554.17 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 6,535,187,860.09 | 6,470,335,626.09 | 6,482,044,621.06 | 6,384,825,270.34 |
| 少数股东权益 | 83,161,408.83 | 227,411,930.24 | 230,438,327.41 | 226,636,750.2 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 6,618,349,268.92 | 6,697,747,556.33 | 6,712,482,948.47 | 6,611,462,020.54 |
| 负债和股东权益合计 | 8,205,887,219.8 | 8,303,136,615.46 | 8,124,498,732.44 | 8,119,249,307.93 |
| 公告日期 | 2024-10-23 | 2024-08-02 | 2024-04-25 | 2024-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |